DUBLIN–(BUSINESS WIRE)–The “Orthobiologics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026” report has been added to ResearchAndMarkets.com’s offering.
Global Orthobiologics Market: Overview
This report analyzes the current and future scenario of the global orthobiologics market. Surge in the number of orthopedic procedures, increase in demand for biologics in spinal surgery and traumatic injuries, and rise in prevalence of chronic arthritis are projected to drive the global market. Additionally, rise in prevalence of sports injuries propels the global orthobiologics market.
This report comprises an elaborate executive summary, which includes information about various segments of the global orthobiologics market. It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global orthobiologics market.
Global Orthobiologics Market: Key Segments
In terms of product, the global orthobiologics market has been segmented into bone morphogenetic proteins, demineralized bone matrix, synthetic bone substitutes, viscosupplements, allografts, stem cell, and others. Based on application, the global market has been classified into spinal fusion, trauma repair, reconstructive surgeries, and others. In terms of end-user, the global orthobiologics market has been segmented into hospitals, orthopedic clinics, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Key Topics Covered:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthobiologics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1 Rise in Prevalence of Chronic Arthritis
4.3.1.2 Surge in Sports Injuries
4.3.1.3 Demand for Innovative Product
4.3.2. Restraints
4.3.2.1 Lack of Reimbursement
4.3.2.2 Stringent Regulatory Requirement
4.3.3. Opportunities
4.3.3.1 Increase in focus on stem cell based matrices
4.3.3.2 Launch of new products and acquisition in emerging markets
4.4. Global Orthobiologics Market Analysis and Forecast, 2016-2026
5. Key Insights
5.1.Key Market Trends
5.2. Merger and Acquisition
5.3 Strategies of Top Five Players Operating in the Market
5.4 Incidence of Orthopedic Disorder, by Key Countries
5.5. Regulatory and Reimbursement Scenario, by Key Countries
6. Global Orthobiologics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Market Value Forecast, by Product, 2016-2026
6.4. Market Attractiveness, by Product
7. Global Orthobiologics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Market Value Forecast, by Application, 2016-2026
7.3. Market Attractiveness, by Application
8. Global Orthobiologics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Market Value Forecast, by End-user, 2016-2026
8.3. Market Attractiveness, by End-user
9. Global Orthobiologics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.3. Market Attractiveness, by Country/Region
10. North America Orthobiologics Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Product, 2016-2026
10.3. Market Value Forecast, by Application, 2016-2026
10.4. Market Value Forecast, by End-user, 2016-2026
10.5. Market Value Forecast, by Country, 2016-2026
10.6. Market Attractiveness Analysis
11. Europe Orthobiologics Market Analysis and Forecast
12. Asia Pacific Orthobiologics Market Analysis and Forecast
13. Latin America Orthobiologics Market Analysis and Forecast
14. Middle East & Africa Orthobiologics Market Analysis and Forecast
15. Competition Landscape
15.1. Global Orthobiologics Market Analysis, by Top Company Ranking, 2017
15.2. Global Orthobiologics Market Position Analysis, by Company
15.3. Company Profiles
15.3.1. Medtronic
15.3.2. DePuy Synthes (Johnson & Johnson)
15.3.3. Sanofi
15.3.4. Seikagaku Corporation
15.3.5. Stryker
15.3.6. MTF Biologics
15.3.7. Bioventus LLC
15.3.8. Arthrex
15.3.9. Zimmer Biomet
15.3.10 RTI Surgical, Inc.
15.3.11. Alphatec Spine, Inc.
15.3.12. Exactech, Inc.
15.3.13. Globus Medical, Inc.
15.3.14. Integra LifeSciences
For more information about this report visit https://www.researchandmarkets.com/r/9cc4dx
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900